7Baggers

EXC Stock Cash Flow Statements

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
     Operating Cash Flow  
     Investing Cash Flow  
     Financing Cash Flow  
     Net Income  
    Quarterly
     | 
    Annual
     
    20120331 20120630 20120930 20130331 20150331 20150630 20150930 20220331 20220630 20230331 0105.43210.86316.29421.71527.14632.57738Milllion
    Quarterly Cash Flow Statements
    Quarterly
     | 
    Annual
     
      Unit: USD2023-03-31 2022-06-30 2022-03-31 2015-09-30 2015-06-30 2015-03-31 2013-03-31 2012-09-30 2012-06-30 2012-03-31 
                  
        cash flows from operating activities          
        net income669,000,000 465,000,000 598,000,000 587,000,000 634,000,000 738,000,000 1,000,000 297,000,000 290,000,000 200,000,000 
        adjustments to reconcile net income to net cash flows from operating activities:          
        depreciation, amortization, and accretion, including nuclear fuel and energy contract amortization860,000,000 830,000,000 1,024,000,000        
        gain on sales of assets and businesses 2,000,000 -10,000,000        
        deferred income taxes and amortization of investment tax credits113,000,000 33,000,000 110,000,000 30,000,000 82,000,000 129,000,000 -610,000,000 36,000,000 126,000,000 101,000,000 
        net fair value changes related to derivatives 0 -59,000,000 144,000,000 -416,000,000 -91,000,000 388,000,000 -54,000,000 -250,000,000 -73,000,000 
        net realized and unrealized losses on ndt funds          
        net unrealized losses on equity investments  16,000,000        
        other non-cash operating activities-138,000,000 44,000,000 232,000,000 277,000,000 235,000,000 344,000,000 231,000,000 276,000,000 429,000,000 530,000,000 
        changes in assets and liabilities:          
        accounts receivable106,000,000 -84,000,000 -711,000,000 -78,000,000 523,000,000 -270,000,000 -70,000,000 -174,000,000 20,000,000 394,000,000 
        inventories102,000,000 -113,000,000 125,000,000 -94,000,000 -132,000,000 291,000,000 101,000,000 -33,000,000 -59,000,000 104,000,000 
        accounts payable and accrued expenses-482,000,000 253,000,000 291,000,000        
        option premiums paid      -3,000,000    
        collateral (paid) received-214,000,000          
        income taxes23,000,000 -54,000,000 77,000,000 53,000,000 73,000,000 174,000,000 632,000,000 206,000,000 81,000,000 178,000,000 
        regulatory assets and liabilities-324,000,000          
        pension and non-pension postretirement benefit contributions-44,000,000 -11,000,000 -574,000,000 -129,000,000 -32,000,000 -269,000,000 -267,000,000 -41,000,000 -35,000,000 -55,000,000 
        other assets and liabilities-187,000,000 -78,000,000 -645,000,000 -694,000,000 99,000,000 115,000,000 233,000,000 -74,000,000 -235,000,000 -122,000,000 
        net cash flows from operating activities484,000,000 1,458,000,000 1,782,000,000 1,705,000,000 2,479,000,000 1,490,000,000 859,000,000 1,828,000,000 1,735,000,000 994,000,000 
        cash flows from investing activities          
        capital expenditures-1,881,000,000 -1,585,000,000 -1,922,000,000 -1,983,000,000 -1,676,000,000 -1,784,000,000 -1,447,000,000 -1,329,000,000 -1,320,000,000 -1,496,000,000 
        proceeds from ndt fund sales 0 488,000,000        
        investment in ndt funds 0 -516,000,000        
        collection of dpp 0 169,000,000        
        proceeds from sales of assets and businesses 0 16,000,000        
        other investing activities10,000,000 58,000,000 -54,000,000 -30,000,000 -75,000,000 -2,000,000 40,000,000 53,000,000 47,000,000 -59,000,000 
        net cash flows used in investing activities-1,871,000,000   -2,143,000,000 -1,795,000,000 -1,751,000,000 -1,471,000,000 -1,341,000,000 -1,344,000,000 -640,000,000 
        cash flows from financing activities          
        changes in short-term borrowings-1,130,000,000 103,000,000 -700,000,000 136,000,000 235,000,000 -141,000,000     
        proceeds from short-term borrowings with maturities greater than 90 days 0 1,150,000,000        
        repayments on short-term borrowings with maturities greater than 90 days-150,000,000 0 -350,000,000        
        issuance of long-term debt3,925,000,000 850,000,000 4,301,000,000 2,000,000 4,701,000,000 1,206,000,000 149,000,000 708,000,000   
        retirement of long-term debt-857,000,000 -1,701,000,000 -6,000,000 -37,000,000 -1,128,000,000 -580,000,000 -1,000,000 -82,000,000 -198,000,000 -451,000,000 
        dividends paid on common stock-358,000,000 -331,000,000 -332,000,000 -282,000,000 -268,000,000 -269,000,000 -450,000,000 -453,000,000 -423,000,000 -350,000,000 
        proceeds from employee stock plans10,000,000 8,000,000 9,000,000 8,000,000 8,000,000 8,000,000 12,000,000 19,000,000 30,000,000 12,000,000 
        transfer of cash, restricted cash, and cash equivalents to constellation 0 -2,594,000,000        
        other financing activities-60,000,000 -22,000,000 -62,000,000 -6,000,000 -43,000,000 -16,000,000 -45,000,000 -10,000,000 -9,000,000 -1,000,000 
        net cash flows from financing activities1,380,000,000 -1,093,000,000 1,416,000,000 1,689,000,000 3,505,000,000 208,000,000  -136,000,000 237,000,000 -649,000,000 
        increase in cash, restricted cash, and cash equivalents-7,000,000 -1,162,000,000 1,379,000,000        
        cash, restricted cash, and cash equivalents at beginning of period1,090,000,000 0 1,619,000,000        
        cash, restricted cash, and cash equivalents at end of period1,083,000,000 -1,162,000,000 2,998,000,000        
        supplemental cash flow information          
        decrease in capital expenditures not paid-201,000,000 46,000,000 -322,000,000        
        increase in dpp 0 348,000,000        
        decrease in pp&e related to aro update          
        asset impairments          
        net realized and unrealized losses (gains) on ndt funds 0 205,000,000        
        net unrealized losses (gains) on equity investments          
        option premiums (paid) received 0 -39,000,000     -14,000,000 -8,000,000 -100,000,000 
        collateral received 547,000,000 1,142,000,000        
        increase in pp&e related to aro update 0 -335,000,000        
        net cash flows from investing activities  -1,819,000,000        
        depreciation, amortization, depletion and accretion, including nuclear fuel and energy contract amortization   973,000,000 1,009,000,000 948,000,000 1,017,000,000    
        impairment of long-lived assets   1,000,000       
        gain on consolidation and acquisition of businesses          
        gain on sales of assets   -2,000,000 -7,000,000 -1,000,000     
        net realized and unrealized (gains) losses on nuclear decommissioning trust fund investments          
        accounts payable, accrued expenses and other current liabilities   521,000,000 -61,000,000 -607,000,000 -542,000,000 226,000,000 113,000,000 -1,176,000,000 
        option premiums received   5,000,000 17,000,000 5,000,000     
        counterparty collateral received (posted)   -112,000,000 386,000,000 31,000,000 -186,000,000 -43,000,000 111,000,000 340,000,000 
        proceeds from nuclear decommissioning trust fund sales   1,237,000,000 1,633,000,000 1,681,000,000 677,000,000 891,000,000 1,691,000,000 3,680,000,000 
        investment in nuclear decommissioning trust funds   -1,300,000,000 -1,690,000,000 -1,747,000,000 -729,000,000 -939,000,000 -1,757,000,000 -3,726,000,000 
        acquisition of businesses   0 -13,000,000 -15,000,000     
        proceeds from sale of long-lived assets   0 3,000,000 142,000,000     
        proceeds from termination of direct financing lease investment          
        proceeds from sales of investments       14,000,000 2,000,000 10,000,000 
        cash and restricted cash acquired from consolidations and acquisitions          
        change in restricted cash   -67,000,000 23,000,000 -26,000,000 -12,000,000 -23,000,000 -7,000,000 -8,000,000 
        issuance of common stock          
        distributions to noncontrolling interest of consolidated vie          
        increase in cash and cash equivalents   1,251,000,000    351,000,000   
        cash and cash equivalents at beginning of period   0 0 1,878,000,000 1,486,000,000 0 0 1,016,000,000 
        cash and cash equivalents at end of period   1,251,000,000 4,189,000,000 1,825,000,000 772,000,000 351,000,000 628,000,000 721,000,000 
        net realized and unrealized gains on nuclear decommissioning trust fund investments    45,000,000 -47,000,000 -66,000,000  33,000,000 -103,000,000 
        decrease in cash and cash equivalents     -53,000,000 -714,000,000   -295,000,000 
        cash and restricted cash acquired from constellation          
        changes in short-term debt      233,000,000 -318,000,000 38,000,000 141,000,000 
        net cash flows used in financing activities      -102,000,000    
        depreciation, amortization, accretion and depletion including nuclear fuel and energy contract amortization       1,014,000,000 1,119,000,000 776,000,000 
        impairment of assets held for sale          
        acquisitions          
        cash acquired from constellation       0 0 964,000,000 
        purchases of investments       -8,000,000 0 -5,000,000 
        dividends paid to former constellation shareholders       0